Your browser doesn't support javascript.
loading
CGG repeat expansion in LRP12 in amyotrophic lateral sclerosis.
Kume, Kodai; Kurashige, Takashi; Muguruma, Keiko; Morino, Hiroyuki; Tada, Yui; Kikumoto, Mai; Miyamoto, Tatsuo; Akutsu, Silvia Natsuko; Matsuda, Yukiko; Matsuura, Shinya; Nakamori, Masahiro; Nishiyama, Ayumi; Izumi, Rumiko; Niihori, Tetsuya; Ogasawara, Masashi; Eura, Nobuyuki; Kato, Tamaki; Yokomura, Mamoru; Nakayama, Yoshiaki; Ito, Hidefumi; Nakamura, Masataka; Saito, Kayoko; Riku, Yuichi; Iwasaki, Yasushi; Maruyama, Hirofumi; Aoki, Yoko; Nishino, Ichizo; Izumi, Yuishin; Aoki, Masashi; Kawakami, Hideshi.
Afiliação
  • Kume K; Department of Molecular Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Kurashige T; Department of Neurology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
  • Muguruma K; Department of iPS Cell Applied Medicine, Graduate School of Medicine, Kansai Medical University, Osaka, Japan.
  • Morino H; Department of Molecular Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Tada Y; Department of Molecular Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Kikumoto M; Department of Molecular Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Miyamoto T; Department of Genetics and Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Akutsu SN; Department of Genetics and Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Matsuda Y; Department of Molecular Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Matsuura S; Department of Genetics and Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Nakamori M; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Nishiyama A; Department of Neurology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Izumi R; Department of Neurology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Niihori T; Department of Medical Genetics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Ogasawara M; Department of Neuromuscular Research, National Institute of Neuroscience, National Centre of Neurology and Psychiatry, National Centre Hospital, Tokyo, Japan.
  • Eura N; Department of Neuromuscular Research, National Institute of Neuroscience, National Centre of Neurology and Psychiatry, National Centre Hospital, Tokyo, Japan.
  • Kato T; Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan.
  • Yokomura M; Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan.
  • Nakayama Y; Department of Neurology, Wakayama Medical University, Wakayama, Japan.
  • Ito H; Department of Neurology, Wakayama Medical University, Wakayama, Japan.
  • Nakamura M; Department of Neurology, Kansai Medical University, Osaka, Japan.
  • Saito K; Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan.
  • Riku Y; Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Japan.
  • Iwasaki Y; Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Japan.
  • Maruyama H; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Aoki Y; Department of Medical Genetics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Nishino I; Department of Neuromuscular Research, National Institute of Neuroscience, National Centre of Neurology and Psychiatry, National Centre Hospital, Tokyo, Japan.
  • Izumi Y; Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Aoki M; Department of Neurology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Kawakami H; Department of Molecular Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. Electronic address: hkawakam@hiroshima-u.ac.jp.
Am J Hum Genet ; 110(7): 1086-1097, 2023 07 06.
Article em En | MEDLINE | ID: mdl-37339631
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the degeneration of motor neurons. Although repeat expansion in C9orf72 is its most common cause, the pathogenesis of ALS isn't fully clear. In this study, we show that repeat expansion in LRP12, a causative variant of oculopharyngodistal myopathy type 1 (OPDM1), is a cause of ALS. We identify CGG repeat expansion in LRP12 in five families and two simplex individuals. These ALS individuals (LRP12-ALS) have 61-100 repeats, which contrasts with most OPDM individuals with repeat expansion in LRP12 (LRP12-OPDM), who have 100-200 repeats. Phosphorylated TDP-43 is present in the cytoplasm of iPS cell-derived motor neurons (iPSMNs) in LRP12-ALS, a finding that reproduces the pathological hallmark of ALS. RNA foci are more prominent in muscle and iPSMNs in LRP12-ALS than in LRP12-OPDM. Muscleblind-like 1 aggregates are observed only in OPDM muscle. In conclusion, CGG repeat expansions in LRP12 cause ALS and OPDM, depending on the length of the repeat. Our findings provide insight into the repeat length-dependent switching of phenotypes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Esclerose Lateral Amiotrófica / Distrofias Musculares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Am J Hum Genet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Esclerose Lateral Amiotrófica / Distrofias Musculares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Am J Hum Genet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão